The present concern of COVID-19 is the rapid emergence of variants of concern of SARS-CoV-2 such as Omicron that showed high transmission potential. Thus, discovering potential drug candidates is one of the utmost concerns. Repurposing FDA-approved drugs that are already in use is probably one of the promising strategies, however, such applications require extensive studies and research. https://www.pharmafocusasia.com/articles/repurposed-drugs-against-the-latest-variants-of-concerns-of-sars-cov-2